|
|
|||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Dr. B. Levin is Professor Emeritus, The University of Texas MD Anderson Cancer Center, Houston, TX.
Dr. Lieberman is Chief, Division of Gastroenterology, Oregon Health and Science University, Portland Veterans Medical Center, Portland, OR.
Dr. McFarland is Adjunct Professor of Radiology, Washington University; St. Luke's Hospital and Center for Diagnostic Imaging, Chesterfield, MO.
Dr. Smith is Director, Cancer Screening, Cancer Control Science Department, American Cancer Society, Atlanta, GA.
Dr. Brooks is Director, Prostate and Colorectal Cancer, Cancer Control Science Department, American Cancer Society, Atlanta, GA.
Ms. Andrews is Research Associate, Cancer Control Science Department, American Cancer Society, Atlanta, GA.
Dr. Dash is Doctoral Candidate, Department of Epidemiology, Emory University, Rollins School of Public Health, Atlanta, GA.
Dr. Giardiello is John G. Rangos Sr. Professor of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD.
Dr. Glick is Clinical Professor of Radiology, University of Pennsylvania Health System, Philadelphia, PA.
Dr. T. Levin is Staff Physician, Gastroenterology Department, Kaiser Permanente Walnut Creek Medical Center, Walnut Creek, CA.
Dr. Pickhardt is Associate Professor, Radiology Department, University of Wisconsin Hospital and Clinics, Madison, WI.
Dr. Rex is Professor of Medicine, Indiana University, Indianapolis, IN.
Dr. Thorson is Associate Professor of Surgery; and Program Director, Section of Colon and Rectal Surgery, Creighton University School of Medicine; and Clinical Associate Professor of Surgery, University of Nebraska College of Medicine, Omaha, NE.
Dr. Winawer is Attending Physician, Memorial Sloan-Kettering Cancer Center, New York, NY.
Disclosures: Workgroup members were asked to disclose relationships, including potential financial conflicts of interest. The following was disclosed: D. Lieberman served on the scientific advisory board for Exact Sciences, ending September 30, 2007. B. McFarland receives honoraria for serving on the medical advisory boards for Vital Images and Medicsight. P. Pickhardt serves as a paid consultant to Covidien, Viatronix, Fleet, Medicsight, and Philips. D. Rex receives an honorarium for serving as a speaker and research support for serving as an investigator for Olympus; serves on the scientific advisory board and receives research support for serving as an investigator for Given Imaging; and serves on the scientific advisory boards for Avantis, NeoGuide, G.I. View, and American BioOptics. M. Rodriguez-Bigas is on the speakers bureau of Genzyme. R. Wender serves on the scientific advisory boards for Epigenomics, GeneNews, and G.I. View, but receives no personal income for doing so. D. Johnson serves as an Exact Sciences clinical investigator, but has received no support since 2006. C. D. Johnson and Mayo Clinic have licensed a CT colonography software patent to GE Medical Systems.
Published online through CA First Look at http://CAonline.AmCancer.Soc.org.
To earn free CME credit for successfully completing the online quiz based on this article, go to http://CME.AmCancerSoc.org.
In the United States, colorectal cancer (CRC) is the third most common cancer diagnosed among men and women and the second leading cause of death from cancer. CRC largely can be prevented by the detection and removal of adenomatous polyps, and survival is significantly better when CRC is diagnosed while still localized. In 2006 to 2007, the American Cancer Society, the US Multi Society Task Force on Colorectal Cancer, and the American College of Radiology came together to develop consensus guidelines for the detection of adenomatous polyps and CRC in asymptomatic average-risk adults. In this update of each organization's guidelines, screening tests are grouped into those that primarily detect cancer early and those that can detect cancer early and also can detect adenomatous polyps, thus providing a greater potential for prevention through polypectomy. When possible, clinicians should make patients aware of the full range of screening options, but at a minimum they should be prepared to offer patients a choice between a screening test that is effective at both early cancer detection and cancer prevention through the detection and removal of polyps and a screening test that primarily is effective at early cancer detection. It is the strong opinion of these 3 organizations that colon cancer prevention should be the primary goal of screening.
This article has been cited by other articles:
![]() |
G. Konrad Dietary interventions for fecal occult blood test screening: Systematic review of the literature Can Fam Physician, March 1, 2010; 56(3): 229 - 238. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. K. Shokar, C. A. Carlson, and S. C. Weller Informed Decision Making Changes Test Preferences for Colorectal Cancer Screening in a Diverse Population Ann. Fam. Med, March 1, 2010; 8(2): 141 - 150. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Smith, V. Cokkinides, D. Brooks, D. Saslow, and O. W. Brawley Cancer Screening in the United States, 2010: A Review of Current American Cancer Society Guidelines and Issues in Cancer Screening CA Cancer J Clin, March 1, 2010; 60(2): 99 - 119. [Abstract] [Full Text] [PDF] |
||||
![]() |
E.-Y. Cha, S. H. Park, S. S. Lee, J. C. Kim, C. S. Yu, S.-B. Lim, S. N. Yoon, Y. M. Shin, A. Y. Kim, and H. K. Ha CT Colonography after Metallic Stent Placement for Acute Malignant Colonic Obstruction Radiology, March 1, 2010; 254(3): 774 - 782. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kumar Pal, V. Katheria, and A. Hurria Evaluating the Older Patient with Cancer: Understanding Frailty and the Geriatric Assessment CA Cancer J Clin, March 1, 2010; 60(2): 120 - 132. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. H. Kim, P. J. Pickhardt, M. E. Hanson, and J. L. Hinshaw CT Colonography: Performance and Program Outcome Measures in an Older Screening Population Radiology, February 1, 2010; 254(2): 493 - 500. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Brenner, M. Hoffmeister, V. Arndt, C. Stegmaier, L. Altenhofen, and U. Haug Protection From Right- and Left-Sided Colorectal Neoplasms After Colonoscopy: Population-Based Study J Natl Cancer Inst, January 20, 2010; 102(2): 89 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. W. Burt, J. S. Barthel, K. B. Dunn, D. S. David, E. Drelichman, J. M. Ford, F. M. Giardiello, S. B. Gruber, A. L. Halverson, S. R. Hamilton, et al. Colorectal Cancer Screening J Natl Compr Canc Netw, January 1, 2010; 8(1): 8 - 61. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Potack and S. H. Itzkowitz Practical Advances in Stool Screening for Colorectal Cancer J Natl Compr Canc Netw, January 1, 2010; 8(1): 81 - 92. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Sifri, R. Wender, D. Lieberman, M. Potter, K. Peterson, T. K. Weber, and R. Smith Developing a Quality Screening Colonoscopy Referral System in Primary Care Practice: A Report from the National Colorectal Cancer Roundtable CA Cancer J Clin, December 18, 2009; (2009) caac.20048v1. [Abstract] [Full Text] |
||||
![]() |
S. D. Markowitz and M. M. Bertagnolli Molecular Basis of Colorectal Cancer N. Engl. J. Med., December 17, 2009; 361(25): 2449 - 2460. [Full Text] [PDF] |
||||
![]() |
S. Mahgerefteh, S. Fraifeld, A. Blachar, and J. Sosna CT Colonography With Decreased Purgation: Balancing Preparation, Performance, and Patient Acceptance Am. J. Roentgenol., December 1, 2009; 193(6): 1531 - 1539. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Lawsin, K. DuHamel, S. Itzkowitz, K. Brown, H. Lim, and L. Jandorf An Examination of the Psychosocial Factors Influencing Colorectal Cancer Patients' Communication of Colorectal Cancer Patient Risk with Their Siblings Cancer Epidemiol. Biomarkers Prev., November 1, 2009; 18(11): 2907 - 2912. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Center, A. Jemal, R. A. Smith, and E. Ward Worldwide Variations in Colorectal Cancer CA Cancer J Clin, November 1, 2009; 59(6): 366 - 378. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. E. Duncan, M. P. McNally, W. B. Sweeney, A. B. Gentry, D. S. Barlow, D. W. Jensen, and B. D. Cash CT Colonography Predictably Overestimates Colonic Length and Distance to Polyps Compared With Optical Colonoscopy Am. J. Roentgenol., November 1, 2009; 193(5): 1291 - 1295. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. M. Summers, J. A. Swift, A. J. Dwyer, J. R. Choi, and P. J. Pickhardt Normalized Distance Along the Colon Centerline: A Method for Correlating Polyp Location on CT Colonography and Optical Colonoscopy Am. J. Roentgenol., November 1, 2009; 193(5): 1296 - 1304. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Kozu, G. Iinuma, Y. Ohashi, Y. Saito, T. Akasu, D. Saito, D. B. Alexander, M. Iigo, T. Kakizoe, and H. Tsuda Effect of Orally Administered Bovine Lactoferrin on the Growth of Adenomatous Colorectal Polyps in a Randomized, Placebo-Controlled Clinical Trial Cancer Prevention Research, November 1, 2009; 2(11): 975 - 983. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Manne, E. J. Coups, G. Winkel, A. Markowitz, N. J. Meropol, S. M. Lesko, P. B. Jacobsen, D. Haller, L. Jandorf, and S. K. Peterson Identifying cluster subtypes for intentions to have colorectal cancer screening among non-compliant intermediate-risk siblings of individuals with colorectal cancer Health Educ. Res., October 1, 2009; 24(5): 897 - 908. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. D. Cash, S. S. Dhruva, and R. F. Redberg CMS's Landmark Decision on CT Colonography N. Engl. J. Med., September 24, 2009; 361(13): 1316 - 1317. [Full Text] [PDF] |
||||
![]() |
S. H. Itzkowitz Incremental Advances in Excremental Cancer Detection Tests J Natl Cancer Inst, September 16, 2009; 101(18): 1225 - 1227. [Full Text] [PDF] |
||||
![]() |
D. J. Robertson, C. A. Burke, H. G. Welch, R. W. Haile, R. S. Sandler, E. R. Greenberg, D. J. Ahnen, R. S. Bresalier, R. I. Rothstein, B. Cole, et al. Using the Results of a Baseline and a Surveillance Colonoscopy to Predict Recurrent Adenomas With High-Risk Characteristics Ann Intern Med, July 21, 2009; 151(2): 103 - 109. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. H Fletcher Colorectal cancer screening: for prevention or cure? J Epidemiol Community Health, July 1, 2009; 63(7): 505 - 506. [Full Text] [PDF] |
||||
![]() |
D. Huo, J. T. Hetzel, H. Roy, and D. T. Rubin Association of Colorectal Cancer and Prostate Cancer and Impact of Radiation Therapy Cancer Epidemiol. Biomarkers Prev., July 1, 2009; 18(7): 1979 - 1985. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Subramanian, G. Bobashev, and R. J. Morris Modeling the Cost-Effectiveness of Colorectal Cancer Screening: Policy Guidance Based on Patient Preferences and Compliance Cancer Epidemiol. Biomarkers Prev., July 1, 2009; 18(7): 1971 - 1978. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. H. McCollough, L. Guimaraes, and J. G. Fletcher In Defense of Body CT Am. J. Roentgenol., July 1, 2009; 193(1): 28 - 39. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Pickhardt and D. H. Kim Colorectal Cancer Screening With CT Colonography: Key Concepts Regarding Polyp Prevalence, Size, Histology, Morphology, and Natural History Am. J. Roentgenol., July 1, 2009; 193(1): 40 - 46. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. H. Park, S. Y. Kim, S. S. Lee, L. Bogoni, A. Y. Kim, S.-K. Yang, S.-J. Myung, J.-S. Byeon, B. D. Ye, and H. K. Ha Sensitivity of CT Colonography for Nonpolypoid Colorectal Lesions Interpreted by Human Readers and With Computer-Aided Detection Am. J. Roentgenol., July 1, 2009; 193(1): 70 - 78. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Rennert Are We Getting Closer to Molecular Population Screening for Colorectal Cancer? J Natl Cancer Inst, July 1, 2009; 101(13): 902 - 903. [Full Text] [PDF] |
||||
![]() |
T. deVos, R. Tetzner, F. Model, G. Weiss, M. Schuster, J. Distler, K. V. Steiger, R. Grutzmann, C. Pilarsky, J. K. Habermann, et al. Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer Clin. Chem., July 1, 2009; 55(7): 1337 - 1346. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. D. Markowitz, S. H. Itzkowitz, and B. M. Berger The Effectiveness of Colonoscopy in Reducing Mortality From Colorectal Cancer Ann Intern Med, June 2, 2009; 150(11): 816 - 817. [Full Text] [PDF] |
||||
![]() |
M. M. Center, A. Jemal, and E. Ward International Trends in Colorectal Cancer Incidence Rates Cancer Epidemiol. Biomarkers Prev., June 1, 2009; 18(6): 1688 - 1694. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. C. Glockner, M. Dhir, J. M. Yi, K. E. McGarvey, L. Van Neste, J. Louwagie, T. A. Chan, W. Kleeberger, A. P. de Bruine, K. M. Smits, et al. Methylation of TFPI2 in Stool DNA: A Potential Novel Biomarker for the Detection of Colorectal Cancer Cancer Res., June 1, 2009; 69(11): 4691 - 4699. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. M. Croswell, B. S. Kramer, A. R. Kreimer, P. C. Prorok, J.-L. Xu, S. G. Baker, R. Fagerstrom, T. L. Riley, J. D. Clapp, C. D. Berg, et al. Cumulative Incidence of False-Positive Results in Repeated, Multimodal Cancer Screening Ann. Fam. Med, May 1, 2009; 7(3): 212 - 222. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Pickhardt, C. Hassan, A. Laghi, and D. H. Kim CT Colonography to Screen for Colorectal Cancer and Aortic Aneurysm in the Medicare Population: Cost-Effectiveness Analysis Am. J. Roentgenol., May 1, 2009; 192(5): 1332 - 1340. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Gupta Will Test-Specific Adherence Predict the Best Colorectal Cancer Screening Strategy? Ann Intern Med, March 3, 2009; 150(5): 359 - 359. [Full Text] [PDF] |
||||
![]() |
A. G. Zauber, M. van Ballegooijen, and K. M. Kuntz Will Test-Specific Adherence Predict the Best Colorectal Cancer Screening Strategy? Ann Intern Med, March 3, 2009; 150(5): 359 - 360. [Full Text] [PDF] |
||||
![]() |
B. H. Thiers, R. E. Sahn, and J. P. Callen Cutaneous Manifestations of Internal Malignancy CA Cancer J Clin, March 3, 2009; (2009) caac.20005v1. [Abstract] [Full Text] |
||||
![]() |
A. N. Freedman, M. L. Slattery, R. Ballard-Barbash, G. Willis, B. J. Cann, D. Pee, M. H. Gail, and R. M. Pfeiffer Colorectal Cancer Risk Prediction Tool for White Men and Women Without Known Susceptibility J. Clin. Oncol., February 10, 2009; 27(5): 686 - 693. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. J. Fenton, R. J. Reid, L.-M. Baldwin, J. G. Elmore, D. S.M. Buist, and P. Franks Influence of Primary Care Use on Population Delivery of Colorectal Cancer Screening Cancer Epidemiol. Biomarkers Prev., February 1, 2009; 18(2): 640 - 645. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. N. Baxter, M. A. Goldwasser, L. F. Paszat, R. Saskin, D. R. Urbach, and L. Rabeneck Association of Colonoscopy and Death From Colorectal Cancer Ann Intern Med, January 6, 2009; 150(1): 1 - 8. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Jimbo, R. E. Myers, B. Meyer, T. Hyslop, J. Cocroft, B. J. Turner, and D. S. Weinberg Reasons Patients With a Positive Fecal Occult Blood Test Result Do Not Undergo Complete Diagnostic Evaluation Ann. Fam. Med, January 1, 2009; 7(1): 11 - 16. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. B. Potter, L. Phengrasamy, E. S. Hudes, S. J. McPhee, and J. M.E. Walsh Offering Annual Fecal Occult Blood Tests at Annual Flu Shot Clinics Increases Colorectal Cancer Screening Rates Ann. Fam. Med, January 1, 2009; 7(1): 17 - 23. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. A. Smith, V. Cokkinides, and O. W. Brawley Cancer screening in the United States, 2009: A review of current American Cancer Society guidelines and issues in cancer screening CA Cancer J Clin, January 1, 2009; 59(1): 27 - 41. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. M. Sturgeon, M. J. Duffy, U.-H. Stenman, H. Lilja, N. Brunner, D. W. Chan, R. Babaian, R. C. Bast Jr., B. Dowell, F. J. Esteva, et al. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines for Use of Tumor Markers in Testicular, Prostate, Colorectal, Breast, and Ovarian Cancers Clin. Chem., December 1, 2008; 54(12): e11 - e79. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. P. Whitlock, J. S. Lin, E. Liles, T. L. Beil, and R. Fu Screening for Colorectal Cancer: A Targeted, Updated Systematic Review for the U.S. Preventive Services Task Force Ann Intern Med, November 4, 2008; 149(9): 638 - 658. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Pickhardt, C. Hassan, A. Laghi, A. Zullo, D. H. Kim, F. Iafrate, and S. Morini Clinical Management of Small (6- to 9-mm) Polyps Detected at Screening CT Colonography: A Cost-Effectiveness Analysis Am. J. Roentgenol., November 1, 2008; 191(5): 1509 - 1516. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Ahlquist, D. J. Sargent, C. L. Loprinzi, T. R. Levin, D. K. Rex, D. J. Ahnen, K. Knigge, M. P. Lance, L. J. Burgart, S. R. Hamilton, et al. Stool DNA and Occult Blood Testing for Screen Detection of Colorectal Neoplasia Ann Intern Med, October 7, 2008; 149(7): 441 - 450. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. A. Lieberman, J. L. Holub, M. D. Moravec, G. M. Eisen, D. Peters, and C. D. Morris Prevalence of Colon Polyps Detected by Colonoscopy Screening in Asymptomatic Black and White Patients JAMA, September 24, 2008; 300(12): 1417 - 1422. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. P. Mahajan and R. H. Brook Is Patient Cost-Sharing the Best Way to Protect the Medical Commons? Ann Intern Med, September 16, 2008; 149(6): 435 - 436. [Full Text] [PDF] |
||||
![]() |
P. Lance Colorectal Cancer Screening: Confusion Reigns Cancer Epidemiol. Biomarkers Prev., September 1, 2008; 17(9): 2205 - 2207. [Full Text] [PDF] |
||||
![]() |
A. McQueen, J. A. Tiro, and S. W. Vernon Construct Validity and Invariance of Four Factors Associated with Colorectal Cancer Screening across Gender, Race, and Prior Screening Cancer Epidemiol. Biomarkers Prev., September 1, 2008; 17(9): 2231 - 2237. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. G. McFarland, B. Levin, D. A. Lieberman, P. J. Pickhardt, C. D. Johnson, S. N. Glick, D. Brooks, and R. A. Smith Revised Colorectal Screening Guidelines: Joint Effort of the American Cancer Society, U.S. Multisociety Task Force on Colorectal Cancer, and American College of Radiology Radiology, September 1, 2008; 248(3): 717 - 720. [Full Text] [PDF] |
||||
![]() |
A. P. Mahajan and R. H. Brook High-Deductible Health Plans and Better Benefit Design Ann Intern Med, May 6, 2008; 148(9): 704 - 706. [Full Text] [PDF] |
||||
![]() |
R. A. Smith, V. Cokkinides, and O. W. Brawley Cancer Screening in the United States, 2008: A Review of Current American Cancer Society Guidelines and Cancer Screening Issues CA Cancer J Clin, May 1, 2008; 58(3): 161 - 179. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | COVER ARCHIVE | SEARCH | TABLE OF CONTENTS |